Table 2.

Complications Associated with Implantation of Cardiac Implantable Electronic Devices.

Complication	Incidence
Mortality (procedure-related)	<0.1%
Pneumothorax	0.4–2.8%
Perforation	0.1–1.5%
Cardiac tamponade	0.5–1.5%
Pocket hematoma	0.2–16.0%
Infection	0.6–3.4%
Lead dislodgement	1.2–3.3%
Other	<0.5%

Adapted from Burri H et al. EHRA consensus statement on optimal implantation technique for conventional pacemaker and implantable cardioverter defibrillators [25]. These data reflect both pacemaker and defibrillator implantation. Cardiac resynchronization therapy was under-represented. Incidence ranges capture both single- and dual-chamber devices.